Follow the people · Insider
Katherine Stueland
Katherine Stueland files insider transactions with the SEC as a chief executive officer of GeneDx Holdings (WGS). We hold 8 disclosed purchases and sales filed since 7 February 2017, 2 of them in the last 90 days.
- Files forWGS
- Disclosed buys and sells8 in all, 2 in the last 90 days
- Last disclosure18 June 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 9 March 2023 — 16 June 2026Chief Executive Officer · GeneDx Holdings (WGS)229 Form 4 lines · source: SEC Form 4
- Filed 2 May 2022 — 9 December 2022Chief Executive Officer · Sema4 Holdings (SMFR)5 Form 4 lines · source: SEC Form 4
- Filed 3 February 2017 — 14 June 2021Chief Commercial Officer · Invitae (NVTA)73 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 18,750 shares of GeneDx HoldingsSEC Form 418 June 2026Class A Common Stock · traded 16 June 2026 · filed 18 June 2026
- ▼ sold on the open market 2,140 shares of GeneDx HoldingsSEC Form 418 June 2026Class A Common Stock · traded 16 June 2026 · filed 18 June 2026
- ▼ sold on the open market 5,932 shares of GeneDx HoldingsSEC Form 418 June 2026Class A Common Stock · traded 16 June 2026 · filed 18 June 2026
- ▼ sold on the open market 2,429 shares of GeneDx HoldingsSEC Form 418 June 2026Class A Common Stock · traded 16 June 2026 · filed 18 June 2026
- exercised options over 18,750 shares of GeneDx Holdings (a derivative holding)SEC Form 418 June 2026Restricted Stock Unit · traded 16 June 2026 · filed 18 June 2026
- exercised options over 6,546 shares of GeneDx HoldingsSEC Form 411 June 2026Class A Common Stock · traded 9 June 2026 · filed 11 June 2026
- ▼ sold on the open market 3,639 shares of GeneDx HoldingsSEC Form 411 June 2026Class A Common Stock · traded 9 June 2026 · filed 11 June 2026
- exercised options over 6,546 shares of GeneDx Holdings (a derivative holding)SEC Form 411 June 2026Restricted Stock Unit · traded 9 June 2026 · filed 11 June 2026
- exercised options over 3,874 shares of GeneDx HoldingsSEC Form 41 May 2026Class A Common Stock · traded 29 April 2026 · filed 1 May 2026
- ▼ sold on the open market 2,154 shares of GeneDx HoldingsSEC Form 41 May 2026Class A Common Stock · traded 29 April 2026 · filed 1 May 2026
- ▼ sold on the open market 18 shares of GeneDx HoldingsSEC Form 41 May 2026Class A Common Stock · traded 29 April 2026 · filed 1 May 2026
- exercised options over 3,874 shares of GeneDx Holdings (a derivative holding)SEC Form 41 May 2026Restricted Stock Unit · traded 29 April 2026 · filed 1 May 2026
- exercised options over 80,000 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 13,229 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 5,117 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- exercised options over 80,000 shares of GeneDx Holdings (a derivative holding)SEC Form 430 March 2026Restricted Stock Unit · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 13,412 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 5,292 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 9,883 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- exercised options over 80,000 shares of GeneDx Holdings (a derivative holding)SEC Form 430 March 2026Restricted Stock Unit · traded 26 March 2026 · filed 30 March 2026
- exercised options over 80,000 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 13,229 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 5,117 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 13,412 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 5,292 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- ▼ sold on the open market 9,883 shares of GeneDx HoldingsSEC Form 430 March 2026Class A Common Stock · traded 26 March 2026 · filed 30 March 2026
- exercised options over 11,921 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 15 March 2026 · filed 17 March 2026
- exercised options over 18,750 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 7,178 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 16 March 2026 · filed 17 March 2026
- exercised options over 11,921 shares of GeneDx Holdings (a derivative holding)SEC Form 417 March 2026Restricted Stock Unit · traded 15 March 2026 · filed 17 March 2026
- exercised options over 18,750 shares of GeneDx Holdings (a derivative holding)SEC Form 417 March 2026Restricted Stock Unit · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 9,229 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 772 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 16 March 2026 · filed 17 March 2026
- exercised options over 11,921 shares of GeneDx Holdings (a derivative holding)SEC Form 417 March 2026Restricted Stock Unit · traded 15 March 2026 · filed 17 March 2026
- exercised options over 18,750 shares of GeneDx Holdings (a derivative holding)SEC Form 417 March 2026Restricted Stock Unit · traded 16 March 2026 · filed 17 March 2026
- exercised options over 11,921 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 15 March 2026 · filed 17 March 2026
- exercised options over 18,750 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 7,178 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 9,229 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 772 shares of GeneDx HoldingsSEC Form 417 March 2026Class A Common Stock · traded 16 March 2026 · filed 17 March 2026
- exercised options over 6,546 shares of GeneDx HoldingsSEC Form 411 March 2026Class A Common Stock · traded 9 March 2026 · filed 11 March 2026
- ▼ sold on the open market 3,678 shares of GeneDx HoldingsSEC Form 411 March 2026Class A Common Stock · traded 9 March 2026 · filed 11 March 2026
- exercised options over 6,546 shares of GeneDx Holdings (a derivative holding)SEC Form 411 March 2026Restricted Stock Unit · traded 9 March 2026 · filed 11 March 2026
- exercised options over 6,546 shares of GeneDx Holdings (a derivative holding)SEC Form 411 March 2026Restricted Stock Unit · traded 9 March 2026 · filed 11 March 2026
- exercised options over 6,546 shares of GeneDx HoldingsSEC Form 411 March 2026Class A Common Stock · traded 9 March 2026 · filed 11 March 2026
- ▼ sold on the open market 3,678 shares of GeneDx HoldingsSEC Form 411 March 2026Class A Common Stock · traded 9 March 2026 · filed 11 March 2026
- was granted 3,404 shares of GeneDx HoldingsSEC Form 49 March 2026Class A Common Stock · traded 6 March 2026 · filed 9 March 2026
- was granted 3,404 shares of GeneDx HoldingsSEC Form 49 March 2026Class A Common Stock · traded 6 March 2026 · filed 9 March 2026
- was granted 47,684 shares of GeneDx HoldingsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- ▼ sold on the open market 5,861 shares of GeneDx HoldingsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- ▼ sold on the open market 10,465 shares of GeneDx HoldingsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- was granted 40,418 shares of GeneDx Holdings (a derivative holding)SEC Form 45 March 2026Restricted Stock Unit · traded 3 March 2026 · filed 5 March 2026
- ▼ sold on the open market 9,133 shares of GeneDx HoldingsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- was granted 40,418 shares of GeneDx Holdings (a derivative holding)SEC Form 45 March 2026Restricted Stock Unit · traded 3 March 2026 · filed 5 March 2026
- was granted 47,684 shares of GeneDx HoldingsSEC Form 45 March 2026Class A Common Stock · traded 3 March 2026 · filed 5 March 2026
- ▼ sold on the open market 5,861 shares of GeneDx HoldingsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- ▼ sold on the open market 10,465 shares of GeneDx HoldingsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- ▼ sold on the open market 9,133 shares of GeneDx HoldingsSEC Form 45 March 2026Class A Common Stock · traded 4 March 2026 · filed 5 March 2026
- exercised options over 3,874 shares of GeneDx HoldingsSEC Form 42 February 2026Class A Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 1,653 shares of GeneDx HoldingsSEC Form 42 February 2026Class A Common Stock · traded 29 January 2026 · filed 2 February 2026
- exercised options over 3,874 shares of GeneDx Holdings (a derivative holding)SEC Form 42 February 2026Restricted Stock Unit · traded 29 January 2026 · filed 2 February 2026
- exercised options over 3,874 shares of GeneDx Holdings (a derivative holding)SEC Form 42 February 2026Restricted Stock Unit · traded 29 January 2026 · filed 2 February 2026
- exercised options over 3,874 shares of GeneDx HoldingsSEC Form 42 February 2026Class A Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 1,653 shares of GeneDx HoldingsSEC Form 42 February 2026Class A Common Stock · traded 29 January 2026 · filed 2 February 2026
- exercised options over 18,750 shares of GeneDx Holdings (a derivative holding)SEC Form 418 December 2025Restricted Stock Unit · traded 16 December 2025 · filed 18 December 2025
- exercised options over 18,750 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 369 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 1,031 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 2,679 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 604 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 940 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 1,628 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 1,970 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 932 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 274 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 74 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 356 shares of GeneDx HoldingsSEC Form 418 December 2025Class A Common Stock · traded 16 December 2025 · filed 18 December 2025
- exercised options over 6,547 shares of GeneDx Holdings (a derivative holding)SEC Form 411 December 2025Restricted Stock Unit · traded 9 December 2025 · filed 11 December 2025
- exercised options over 6,547 shares of GeneDx HoldingsSEC Form 411 December 2025Class A Common Stock · traded 9 December 2025 · filed 11 December 2025
- ▼ sold on the open market 3,639 shares of GeneDx HoldingsSEC Form 411 December 2025Class A Common Stock · traded 9 December 2025 · filed 11 December 2025
- exercised options over 3,874 shares of GeneDx Holdings (a derivative holding)SEC Form 431 October 2025Restricted Stock Unit · traded 29 October 2025 · filed 31 October 2025
- exercised options over 3,874 shares of GeneDx HoldingsSEC Form 431 October 2025Class A Common Stock · traded 29 October 2025 · filed 31 October 2025
- ▼ sold on the open market 2,154 shares of GeneDx HoldingsSEC Form 431 October 2025Class A Common Stock · traded 29 October 2025 · filed 31 October 2025
- ▼ sold on the open market 4 shares of GeneDx HoldingsSEC Form 431 October 2025Class A Common Stock · traded 29 October 2025 · filed 31 October 2025
- ▼ sold on the open market 606 shares of GeneDx HoldingsSEC Form 41 October 2025Class A Common Stock · traded 30 September 2025 · filed 1 October 2025
- ▼ sold on the open market 1,092 shares of GeneDx HoldingsSEC Form 41 October 2025Class A Common Stock · traded 30 September 2025 · filed 1 October 2025
- ▼ sold on the open market 4,462 shares of GeneDx HoldingsSEC Form 41 October 2025Class A Common Stock · traded 30 September 2025 · filed 1 October 2025
- ▼ sold on the open market 5,163 shares of GeneDx HoldingsSEC Form 41 October 2025Class A Common Stock · traded 30 September 2025 · filed 1 October 2025
- ▼ sold on the open market 554 shares of GeneDx HoldingsSEC Form 41 October 2025Class A Common Stock · traded 30 September 2025 · filed 1 October 2025
- ▼ sold on the open market 200 shares of GeneDx HoldingsSEC Form 41 October 2025Class A Common Stock · traded 30 September 2025 · filed 1 October 2025
- ▼ sold on the open market 645 shares of GeneDx HoldingsSEC Form 41 October 2025Class A Common Stock · traded 30 September 2025 · filed 1 October 2025
- ▼ sold on the open market 136 shares of GeneDx HoldingsSEC Form 41 October 2025Class A Common Stock · traded 30 September 2025 · filed 1 October 2025
- exercised options over 18,750 shares of GeneDx Holdings (a derivative holding)SEC Form 418 September 2025Restricted Stock Unit · traded 16 September 2025 · filed 18 September 2025
- exercised options over 18,750 shares of GeneDx HoldingsSEC Form 418 September 2025Class A Common Stock · traded 16 September 2025 · filed 18 September 2025
- ▼ sold on the open market 10,501 shares of GeneDx HoldingsSEC Form 418 September 2025Class A Common Stock · traded 16 September 2025 · filed 18 September 2025
- exercised options over 6,546 shares of GeneDx Holdings (a derivative holding)SEC Form 411 September 2025Restricted Stock Unit · traded 9 September 2025 · filed 11 September 2025
- exercised options over 6,546 shares of GeneDx HoldingsSEC Form 411 September 2025Class A Common Stock · traded 9 September 2025 · filed 11 September 2025
- ▼ sold on the open market 3,639 shares of GeneDx HoldingsSEC Form 411 September 2025Class A Common Stock · traded 9 September 2025 · filed 11 September 2025
- ▼ sold on the open market 18 shares of GeneDx HoldingsSEC Form 411 September 2025Class A Common Stock · traded 9 September 2025 · filed 11 September 2025
- exercised options over 3,874 shares of GeneDx Holdings (a derivative holding)SEC Form 431 July 2025Restricted Stock Unit · traded 29 July 2025 · filed 31 July 2025
- exercised options over 3,874 shares of GeneDx HoldingsSEC Form 431 July 2025Class A Common Stock · traded 29 July 2025 · filed 31 July 2025
- ▼ sold on the open market 2,154 shares of GeneDx HoldingsSEC Form 431 July 2025Class A Common Stock · traded 29 July 2025 · filed 31 July 2025
- ▼ sold on the open market 3,220 shares of GeneDx HoldingsSEC Form 411 July 2025Class A Common Stock · traded 9 July 2025 · filed 11 July 2025
- ▼ sold on the open market 6,928 shares of GeneDx HoldingsSEC Form 43 July 2025Class A Common Stock · traded 1 July 2025 · filed 3 July 2025
- ▼ sold on the open market 2,594 shares of GeneDx HoldingsSEC Form 43 July 2025Class A Common Stock · traded 1 July 2025 · filed 3 July 2025
- ▼ sold on the open market 135 shares of GeneDx HoldingsSEC Form 43 July 2025Class A Common Stock · traded 1 July 2025 · filed 3 July 2025
- exercised options over 18,750 shares of GeneDx Holdings (a derivative holding)SEC Form 418 June 2025Restricted Stock Unit · traded 16 June 2025 · filed 18 June 2025
- exercised options over 18,750 shares of GeneDx HoldingsSEC Form 418 June 2025Class A Common Stock · traded 16 June 2025 · filed 18 June 2025
- ▼ sold on the open market 10,501 shares of GeneDx HoldingsSEC Form 418 June 2025Class A Common Stock · traded 16 June 2025 · filed 18 June 2025
- exercised options over 6,547 shares of GeneDx Holdings (a derivative holding)SEC Form 411 June 2025Restricted Stock Unit · traded 9 June 2025 · filed 11 June 2025
- exercised options over 6,547 shares of GeneDx HoldingsSEC Form 411 June 2025Class A Common Stock · traded 9 June 2025 · filed 11 June 2025
- ▼ sold on the open market 3,639 shares of GeneDx HoldingsSEC Form 411 June 2025Class A Common Stock · traded 9 June 2025 · filed 11 June 2025
- exercised options over 3,874 shares of GeneDx Holdings (a derivative holding)SEC Form 41 May 2025Restricted Stock Unit · traded 29 April 2025 · filed 1 May 2025
- exercised options over 3,874 shares of GeneDx HoldingsSEC Form 41 May 2025Class A Common Stock · traded 29 April 2025 · filed 1 May 2025
- ▼ sold on the open market 2,154 shares of GeneDx HoldingsSEC Form 41 May 2025Class A Common Stock · traded 29 April 2025 · filed 1 May 2025
- ▼ sold on the open market 2,024 shares of GeneDx HoldingsSEC Form 410 April 2025Class A Common Stock · traded 9 April 2025 · filed 10 April 2025
- ▼ sold on the open market 3,134 shares of GeneDx HoldingsSEC Form 410 April 2025Class A Common Stock · traded 9 April 2025 · filed 10 April 2025
- ▼ sold on the open market 3,297 shares of GeneDx HoldingsSEC Form 410 April 2025Class A Common Stock · traded 9 April 2025 · filed 10 April 2025
- ▼ sold on the open market 2,745 shares of GeneDx HoldingsSEC Form 410 April 2025Class A Common Stock · traded 9 April 2025 · filed 10 April 2025
- ▼ sold on the open market 3,175 shares of GeneDx HoldingsSEC Form 410 April 2025Class A Common Stock · traded 9 April 2025 · filed 10 April 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.